| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01DX011 (sc) | mean tumor weight | steriod suspending solution | 2.5 mg/kg/injection | 70.0 | Antitumor endpoint evaluated on day 12; 12/12 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (sc) | mean tumor weight | steriod suspending solution | 3.8 mg/kg/injection | 77.0 | Antitumor endpoint evaluated on day 12; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (sc) | mean tumor weight | steriod suspending solution | 5.0 mg/kg/injection | 57.0 | Antitumor endpoint evaluated on day 12; 12/12 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (sc) | mean tumor weight | steriod suspending solution | 7.5 mg/kg/injection | 68.0 | Antitumor endpoint evaluated on day 12; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (sc) | mean tumor weight | steriod suspending solution | 10.0 mg/kg/injection | 35.0 | Antitumor endpoint evaluated on day 12; 12/12 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (sc) | mean tumor weight | steriod suspending solution | 15.0 mg/kg/injection | 37.0 | Antitumor endpoint evaluated on day 12; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (sc) | mean tumor weight | steriod suspending solution | 20.0 mg/kg/injection | 40.0 | Antitumor endpoint evaluated on day 12; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (sc) | mean tumor weight | steriod suspending solution | 20.0 mg/kg/injection | 25.0 | Antitumor endpoint evaluated on day 12; 12/12 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (sc) | mean tumor weight | steriod suspending solution | 40.0 mg/kg/injection | 20.0 | Antitumor endpoint evaluated on day 12; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (sc) | mean tumor weight | steriod suspending solution | 40.0 mg/kg/injection | 14.0 | Antitumor endpoint evaluated on day 12; 11/12 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (sc) | mean tumor weight | steriod suspending solution | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 12; 06/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (sc) | mean tumor weight | steriod suspending solution | 80.0 mg/kg/injection | 6.0 | Antitumor endpoint evaluated on day 12; 12/12 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (sc) | mean tumor weight | steriod suspending solution | 160.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 12; 04/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (sc) | mean tumor weight | steriod suspending solution | 160.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 12; 11/12 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (sc) | mean tumor weight | steriod suspending solution | 320.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 12; 04/12 animals surviving on tox evaluation day (usually day 5) |